PERSON: Scott Gottlieb

Pfizer, Illumina, Aetion, and Tempus

Board Member

Scott Gottlieb, MD, is a resident fellow at the American Enterprise Institute. From 2017 to 2019 he served as the 23rd commissioner of the Food and Drug Administration. Dr. Gottlieb is also a special partner with the venture capital firm New Enterprise Associates and serves on the boards of Pfizer, Illumina, Aetion, and Tempus.<br> <br> In addition to his frequent testimonies before Congress, Dr. Gottlieb is often published and interviewed by the media. He is a regular guest on Face The Nation and a contributor to CNBC, and his commentary and articles have appeared in Health Affairs, The Wall Street Journal, The Washington Post, and The New York Times, among other outlets.<br> <br> [Https://www.uncontrolledspread.com/]